Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel
NCT ID: NCT01540929
Last Updated: 2024-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5001 participants
OBSERVATIONAL
2009-09-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary Objective:
* To evaluate the accuracy of the DoD smallpox vaccination screening process in military personnel.
Secondary Objective:
* To describe the number of subjects who are excluded from vaccination, stratified by the pre-defined categories for exclusion (separately for the Screened and Evaluable Populations).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
NCT00927719
Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
NCT00928577
Immune Responses to Smallpox Vaccination
NCT00325975
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
NCT00053482
Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
NCT00053495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
DoD Smallpox Screening Form 600 (2 part format)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completion of the DoD Smallpox Screening Form 600 (2-part format).
Exclusion Criteria
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emergent BioSolutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Emergent BioSolutions
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1122-1978
Identifier Type: OTHER
Identifier Source: secondary_id
H-406-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.